Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: A double-blind placebo-controlled trial

Journal of Cardiac Failure

Volumn 17, Issue 11, 2011, Pages 879-886

  Horwich, Tamara B ^a   Middlekauff, Holly R ^a   MacLellan, W Robb ^a   Fonarow, Gregg C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heart failure; lipids; nervous system; sympathetic

Indexed keywords

ALDOSTERONE ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; LOOP DIURETIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; ELECTRONEUROGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; NERVE CONDUCTION; NONISCHEMIC CARDIOMYOPATHY; PERONEUS NERVE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC NERVE;

ANTICHOLESTEREMIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PERONEAL NERVE; PYRROLES; QUESTIONNAIRES; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 80255137147     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2011.07.008     Document Type: Article

References (40)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, and T.M. Brown Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. M. Jessup, and S. Brozena Heart failure N Engl J Med 348 2003 2007 2018
3. T.B. Horwich, W.R. MacLellan, and G.C. Fonarow Statin therapy is associated with improved survival in ischemic and nonischemic heart failure J Am Coll Cardiol 43 2004 642 648 (Pubitemid 38229538)
4. A.S. Go, W.Y. Lee, J. Yang, J.C. Lo, and J.H. Gurwitz Statin therapy and risks for death and hospitalization in chronic heart failure JAMA 296 2006 2105 2111 (Pubitemid 44664705)
5. J.M. Foody, R. Shah, D. Galusha, F.A. Masoudi, E.P. Havranek, and H.M. Krumholz Statins and mortality among elderly patients hospitalized with heart failure Circulation 113 2006 1086 1092
6. R. Patel, S.F. Nagueh, N. Tsybouleva, M. Abdellatif, S. Lutucuta, and H.A. Kopelen Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy Circulation 104 2001 317 324 (Pubitemid 32666954)
7. C. Indolfi, E. Di Lorenzo, C. Perrino, A.M. Stingone, A. Curcio, and D. Torella Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation Circulation 106 2002 2118 2124 (Pubitemid 35192819)
8. K. Node, M. Fujita, M. Kitakaze, M. Hori, and J.K. Liao Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy Circulation 108 2003 839 843 (Pubitemid 37022126)
9. S. Sola, M.Q.S. Mir, S. Lerakis, N. Tandon, and B.V. Khan Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure J Am Coll Cardiol 47 2006 332 337 (Pubitemid 43063250)
10. J. Kjekshus, E. Apetrei, V. Barrios, M. Bohm, J.G. Cleland, and J.H. Cornel Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261 (Pubitemid 350190755)
11. L. Tavazzi, A.P. Maggioni, R. Marchioli, S. Barlera, M.G. Franzosi, and R. Latini Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1231 1239
12. K.K. Khush, and D.D. Waters Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials J Card Fail 12 2006 664 674 (Pubitemid 44512141)
13. R.U. Pliquett, K.G. Cornish, J.D. Peuler, and I.H. Zucker Simvastatin normalizes autonomic neural control in experimental heart failure Circulation 107 2003 2493 2498 (Pubitemid 36605234)
14. R.U. Pliquett, K.G. Cornish, and I.H. Zucker Statin therapy restores sympathovagal balance in experimental heart failure J Appl Physiol 95 2003 700 704 (Pubitemid 36944294)
15. L. Gao, W. Wang, Y.L. Li, H.D. Schultz, D. Liu, and K.G. Cornish Simvastatin therapy normalizes sympathetic neural control in experimental heart failure. Roles of angiotensin II type 1 receptors and NAD(P)H oxidase Circulation 112 2005 1763 1770 (Pubitemid 41368152)
16. B. Vrtovec, R. Okrajsek, A. Golicnik, M. Ferjan, V. Starc, and B. Radovancevic Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure J Card Fail 11 2005 684 690 (Pubitemid 41797497)
17. H.R. Middlekauff, K. Hui, J.L. Yu, M.A. Hamilton, G.C. Fonarow, and J. Moriguchi Acupuncture inhibits sympathetic activation during mental stress in advanced heart failure patients J Card Fail 8 2002 399 406 (Pubitemid 36055742)
18. T. Nahar, L. Croft, R. Shapiro, S. Fruchtman, J. Diamond, and M. Henzlova Comparison of four echocardiographic techniques for measuring left ventricular ejection fraction Am J Cardiol 86 2000 1358 1362
19. T.S. Rector, S.H. Kubo, and J.N. Cohn Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placebo Am J Cardiol 71 1993 1106 1107 (Pubitemid 23126823)
20. H. Krum, E. Ashton, C. Reid, V. Kalff, J. Rogers, and J. Amarena Double-blind, randomized, placebo-controlled study of hiGH-DOSE HMG COA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure J Card Fail 13 2007 1 7 (Pubitemid 46330836)
21. L.D. de Matos, G. Gardenghi, M.U. Rondon, H.N. Soufen, A.P. Tirone, and A.C. Barretto Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients J Card Fail 10 2004 496 502
22. J.N. Cohn, T.B. Levine, M.T. Olivari, V. Garberg, D. Lura, and G.S. Francis Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823 (Pubitemid 14035089)
23. J.S. Floras Sympathetic nervous system activation in human heart failure: clinical implications of an updated model J Am Coll Cardiol 54 2009 375 385
24. F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, and J. Butler The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications J Am Coll Cardiol 54 2009 1747 1762
25. B.G. Wallin, M. Esler, P. Dorward, G. Eisenhofer, C. Ferrier, and R. Westerman Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans J Physiol 453 1992 45 58
26. W.N. Leimbach Jr., B.G. Wallin, R.G. Victor, P.E. Aylward, G. Sundlof, and A.L. Mark Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure Circulation 73 1986 913 919 (Pubitemid 16102181)
27. H.R. Middlekauff, M.A. Hamilton, L.W. Stevenson, and A.L. Mark Independent control of skin and muscle sympathetic nerve activity in patients with heart failure Circulation 90 1994 1794 1798 (Pubitemid 24320927)
28. G. Grassi, G. Seravalle, F. Quarti-Trevano, R. dell'Oro, G. Bolla, and G. Mancia Effects of hypertension and obesity on the sympathetic activation of heart failure patients Hypertension 42 2003 873 877 (Pubitemid 37413723)
29. G. Grassi, B.M. Cattaneo, G. Seravalle, A. Lanfranchi, M. Pozzi, and A. Morganti Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure Circulation 96 1997 1173 1179 (Pubitemid 27344220)
30. M. Hikosaka, F. Yuasa, R. Yuyama, J. Mimura, A. Kawamura, and M. Motohiro Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure J Cardiovasc Pharmacol 40 2002 875 880 (Pubitemid 35365085)
31. M. Gomes, J. Lenders, L. Bellersen, F. Verheugt, P. Smits, and C. Tack Sympathoinhibitory effect of statins in chronic heart failure Clin Auton Res 20 2010 73 78
32. J. Pekkanen, S. Linn, G. Heiss, C.M. Suchindran, A. Leon, and B.M. Rifkind Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease N Engl J Med 322 1990 1700 1707 (Pubitemid 20231527)
33. T.B. Horwich, M.A. Hamilton, W.R. Maclellan, and G.C. Fonarow Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure J Card Fail 8 2002 216 224
34. N. Afsarmanesh, T.B. Horwich, and G.C. Fonarow Total cholesterol levels and mortality risk in nonischemic systolic heart failure Am Heart J 152 2006 1077 1083 (Pubitemid 44854789)
35. S.C. Smith Jr., J. Allen, S.N. Blair, R.O. Bonow, L.M. Brass, and G.C. Fonarow AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2006 2363 2372 (Pubitemid 43947981)
36. S.D. Anker, A.L. Clark, R. Winkler, C. Zugck, M. Cicoira, and P. Ponikowski Statin use and survival in patients with chronic heart failure - results from two observational studies with 5200 patients Int J Cardiol 112 2006 234 242 (Pubitemid 44376681)
37. J.G.F. Cleland, J.J.V. McMurray, J. Kjekshus, J.H. Cornel, P. Dunselman, and C. Fonseca Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) J Am Coll Cardiol 54 2009 1850 1859
38. L.M. Antunes-Correa, R.C. Melo, T.S. Nobre, L.M. Ueno, F.G.M. Franco, and A.M.W. Braga Impact of gender on benefits of exercise training on sympathetic nerve activity and muscle blood flow in heart failure European Journal of Heart Failure 12 2010 58 65
39. S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, and T. Suzuki Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy J Am Coll Cardiol 41 2003 574 581 (Pubitemid 36223322)
40. P.B. Adamson, K.J. Kleckner, W.L. VanHout, S. Srinivasan, and W.T. Abraham Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure Circulation 108 2003 266 269 (Pubitemid 36899014)